The Detroit Tigers head into 2027 with a rotation that looks very different from the one they thought would carry them a year earlier.
What was supposed to be a staff fronted by Tarik Skubal, Framber Valdez, Casey Mize, Jack Flaherty and Justin Verlander never really stayed together long enough to become what Detroit envisioned. Injuries tore through that group, and the only pitcher from the projected 2026 rotation to log 30-plus starts for the club was Valdez. Now he stands as the veteran in a younger mix, and the Tigers are left projecting forward with the arms currently under contract.
Valdez is the obvious place to start. He may not be the name some would choose to lead the group, but he is the most expensive arm on the roster and the most experienced. Detroit gave him a three-year, $115 million deal before spring training 2026, and year two in the Motor City comes with plenty to prove.
His first season with the Tigers was uneven. Valdez finished 2026 with a 4.03 ERA across 31 starts and 174 innings, his highest ERA since 2019 with the Houston Astros and his fewest innings since 2021.
He would be the first to admit the year did not unfold the way anyone expected, but the late-season trend line offered something to work with. He posted a 3.86 ERA in August and a 1.93 ERA in September.
Outside of May and July, when he logged a 5.93 ERA and a 7.13 ERA, he was mostly steady and piled up 16 quality starts.
Behind him, Troy Melton looks like the best bet if his right-arm fatigue does not become an offseason problem again. When he is right, Melton has the kind of stuff that can anchor a staff.
In 2026, he put up a 2.76 ERA in 20 starts during his second big league season and was clearly Detroit’s best pitcher after Skubal was traded to the Dodgers. The talent is obvious; the concern is keeping him healthy and managing the lingering arm issues.
Jackson Jobe should also be in the middle of the rotation, even though he still has not put together a full MLB season. Detroit saw enough from him down the stretch to feel good about the direction he is headed.
Jobe closed 2026 with nine starts, two quality starts, a 3.91 ERA in 46 innings, 51 strikeouts and a 1.17 WHIP. The numbers moved in the right direction from 2025, and the next step is proving he can handle more than 10 starts in a season.
His triple-digit fastball is already his calling card; the offseason priority is building a putaway pitch that can take his game to another level.
Keider Montero earned his place too. His 2026 breakout was too strong to ignore, even though he came out of the bullpen.
Montero emerged as one of Detroit’s most reliable starters in the summer, posting career bests in ERA, WHIP, innings and strikeouts. He finished at 3.48 ERA, 1.04 WHIP, 155 innings and 107 strikeouts, and with Scott Harris focused on developing talent from within, he fits naturally in the 2027 mix.
The back end could hinge on health, starting with Reese Olson. If he is ready after missing all of 2026, he could be part of the rotation picture from the start.
River Ryan also makes sense for starts late in the staff, and the two could split or rotate those opportunities. Ryan flashed in a small sample in September after rehabbing an injury, though it was clear he still was not fully himself.
That final rotation spot remains unsettled, with Ty Madden and Olson both pushing for larger roles next season.
In Other News...
Tigers May Have Found A Cheaper Matt Vierling Replacement
Scott Harris has made it pretty clear that Detroit is leaning toward a younger, cheaper way of building the roster, which makes the Tigers offseason feel a little different than the usual free-agent shopping spree. With Gleyber Torres potentially headed out and Matt Vierling possibly on the non-tender bubble, there is at least one opening on the roster that could be filled without forcing the club into a pricey commitment.
One name that fits that profile is Mauricio Dubn, a free-agent utility player whose value starts with the glove but got a boost from a career-best offensive season. For a Tigers team looking for flexibility, dependable defense and some lineup competence without paying a premium, he checks a lot of boxes. The question is whether Detroit sees him as the kind of practical fit that can replace what it might lose, or whether the market pushes the club in a different direction. [Read more 🡒]
Riley Greene Just Gave Tigers Fans A Reason To Celebrate
Riley Greenes breakout season has put him in some pretty rare company, and now he has another notable honor to go with it: a Hank Aaron Award nomination for his offensive production. For a Tigers club still trying to build around young talent, Greenes emergence has been one of the clearest signs that the offense may have a real centerpiece to lean on moving forward.
Greenes recognition also stands out in a baseball landscape full of bigger postseason headlines, from the White Soxs strong run to the latest twists around Shohei Ohtani and a busy stretch of trades, injuries and team evaluations across the league. Even with all that noise, Detroit has its own reason to pay attention here, because nominations like this tend to confirm what the eye test already suggested - Greenes bat has started to carry real weight. [Read more 🡒]
Tigers Can't Fix This Roster Until Scott Harris Solves One Problem
The Tigers spent 2026 living with too much uncertainty in the late innings, and the numbers told the story as plainly as anything can in a bullpen: 32 saves, 32 blown saves. For a club trying to turn a promising roster into a sturdier contender, that kind of volatility has a way of infecting everything else, because even good starts and timely offense can get wiped away once the game gets to the back end.
Scott Harris has already acknowledged the roster lacks depth, and the offseason picture now looks pretty clear from Detroits side. The Tigers have a club option on Kenley Jansen, but whether they keep him or move in another direction, the bigger task is finding a dependable late-inning arm they can trust when games get tight in September and beyond. David Bednar is one of the names that fits the mold, though for now its still just about identifying the fix, not announcing one. [Read more 🡒]